Phone:
(+212)6814-6992
Physical address:
Cardioplus, Green street, Casablanca, Morocco.
EKOS™ – Endovascular System
The EKOS™ Endovascular System is designed for the treatment of pulmonary embolism, deep vein thrombosis, and peripheral arterial occlusions using ultrasound-assisted, catheter-directed thrombolysis. This minimally invasive procedure employs targeted ultrasonic waves to accelerate clot dissolution by unwinding the fibrin matrix and enhancing drug penetration.
Benefits
- Accelerated Clot Dissolution: Ultrasound waves unwind fibrin strands, exposing more drug receptor sites.
- Lower Lytic Doses: Requires minimal thrombolytic agents, reducing the risk of bleeding.
- Minimally Invasive: Quick procedure with reduced trauma and blood loss.
Technical Parameters
- Infusion Catheter: Delivers thrombolytic drugs directly to the clot.
- Ultrasonic Core: Emits targeted ultrasonic waves for enhanced drug dispersion.
- EKOS+ Catheter: Provides 50% more ultrasound power and 32% more lysis than the previous EKOS version.
Clinical Data
Garcia, Mark J., Keith M. Sterling, Susan R. Kahn, Anthony J. Comerota, Michael R. Jaff, Kenneth Ouriel, Ido Weinberg, et the ACCESS PTS Investigators. « Ultrasound‐Accelerated Thrombolysis and Venoplasty for the Treatment of the Postthrombotic Syndrome: Results of the ACCESS PTS Study ». Journal of the American Heart Association 9, no 3 (4 février 2020): e013398. https://doi.org/10.1161/JAHA.119.013398.
